Monday, October 22, 2018
- 9:00AM-11:00AM
-
Abstract Number: 1351
In Situ Dendritic Cell Characterization in Idiopathic Inflammatory Myopathies
Muscle Biology, Myositis and Myopathies Poster II: Basic and Translational Science- 9:00AM-11:00AM
-
Abstract Number: 982
In the Presence of IL-18, IL-10 but Not IL-6 Induces IFN-γ Production and the Surface Expression of TRAIL on NK Cells
Cytokines and Cell Trafficking Poster- 9:00AM-11:00AM
-
Abstract Number: 1115
In Vivo Assessment of Prevention of Lung Fibrosis Using the Pan-PPAR Agonist Lanifibranor in the Tβriiδk-Fib Mouse Model of Systemic Sclerosis
Systemic Sclerosis and Related Disorders – Basic Science Poster II- 9:00AM-11:00AM
-
Abstract Number: 1736
Incidence and Risk Factors for Gangrene in Patients with Systemic Sclerosis from the Eustar Cohort
Systemic Sclerosis and Related Disorders – Clinical Poster II- 9:00AM-11:00AM
-
Abstract Number: 1234
Incidence of Conversion of Screening Tests for M. Tuberculosis (PPD, GIF-release assay) in a Metropolitan Cohort of Patients Treated with TNF-α Inhibitors
Infection-related Rheumatic Disease Poster- 9:00AM-11:00AM
-
Abstract Number: 1486
Incidence of Subclinical Signs of Inflammation in Patients with New Onset of Non-Specific Musculoskeletal Symptoms and Anti-Citrullinated Peptide Positivity: First Interims Analysis of the Panora Trial
Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster II: Diagnosis and Prognosis- 9:00AM-11:00AM
-
Abstract Number: 1631
Incidence of Uveitis in Patients with Spondyloarthritis: The Impact of Biologics Era.a Multicenter Study Using Data from International ASAS-Comospa Study
Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster II: Clinical/Epidemiology Studies- 9:00AM-11:00AM
-
Abstract Number: 1808
Increased Frequency of Obstructive Sleep Apnea Syndrome in Behcet’s Syndrome Patients with Vena Cava Superior Thrombosis
Vasculitis Poster II: Behҫet’s Disease and IgG4-Related Disease- 9:00AM-11:00AM
-
Abstract Number: 1729
Increased Risk of Valvular Heart Disease in Patients with Systemic Sclerosis: Results from a Population-Based Cohort (1980-2016)
Systemic Sclerosis and Related Disorders – Clinical Poster II- 9:00AM-11:00AM
-
Abstract Number: 1690
Increased Sensitivity Οf Τhe New (2017) Αnd Τhe 2012 SLICC As Compared Τo Τhe Acr 1997 Classification Criteria Ιn Early Systemic Lupus Erythematosus (SLE): The 2017 Αnd 2012 Criteria May Classify Non-Overlapping Subgroups Οf Patients
Systemic Lupus Erythematosus – Clinical Poster II: Biomarkers and Outcomes- 9:00AM-11:00AM
-
Abstract Number: 1799
Increased Vein Wall Thickness in Behçet’s Syndrome
Vasculitis Poster II: Behҫet’s Disease and IgG4-Related Disease- 9:00AM-11:00AM
-
Abstract Number: 1356
Increasing Oral Doses of GLPG1972 Administered Daily for 29 Days Show a Strong Target Engagement in Patients with Knee and/or Hip OA
Osteoarthritis – Clinical Poster II